首页> 外国专利> Use of benzothiophene (raloxifene) derivatives in treatment of osteoporosis, lowering serum cholesterol levels and inhibiting estrogen dependent cancer

Use of benzothiophene (raloxifene) derivatives in treatment of osteoporosis, lowering serum cholesterol levels and inhibiting estrogen dependent cancer

机译:苯并噻吩(雷洛昔芬)衍生物在治疗骨质疏松症,降低血清胆固醇水平和抑制雌激素依赖性癌症中的用途

摘要

This use of benzothiophenes of the formula I ; where R1 is H, OH, alkoxy, OC(O)alkyl, OC(O)Oalkyl, OC(O)phenyl, OC(O)Ophenyl or SO2alkyl, R2 is R1, Cl or F, R3 and R4 each are alkyl or combine to form a morpholine or a 5-8 membered nitrogen containing hetero ring and X is CH2, CHOH, O or CO; is for inhibiting osteoporosis, lowering serum cholesterol levels and inhibiting estrogen-dependent cancer.
机译:式I苯并噻吩的这种用途;其中R1为H,OH,烷氧基,OC(O)烷基,OC(O)O烷基,OC(O)苯基,OC(O)O苯基或SO2烷基,R2为R1,Cl或F,R3和R4各自为烷基或结合形成吗啉或含5-8元氮的杂环,X为CH 2,CHOH,O或CO;用于抑制骨质疏松症,降低血清胆固醇水平和抑制雌激素依赖性癌症。

著录项

  • 公开/公告号NZ333914A

    专利类型

  • 公开/公告日2000-08-25

    原文格式PDF

  • 申请/专利权人 ELI LILLY AND COMPANY;

    申请/专利号NZ19990333914

  • 申请日1999-01-26

  • 分类号A61K31/38;A61K31/445;

  • 国家 NZ

  • 入库时间 2022-08-22 01:55:27

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号